Amicus Therapeutics
Biotechnology rare metabolic diseases
- B2B
- B2C
About Amicus Therapeutics
Global biotechnology company developing innovative medicines for patients with rare metabolic diseases, emphasizing patient collaboration and cutting-edge technology.
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- Princeton, New Jersey, United States
- Founded
- 2002
- Revenue
- $634MFY2025, publicly reported
- Website
- biomarin.com
Amicus Therapeutics at a glance
Amicus Therapeutics is a B2B/B2C company in the Biotechnology Research industry, headquartered in Princeton, New Jersey, United States.
Amicus Therapeutics was founded in 2002.
Amicus Therapeutics has 251–1,000 employees.
Amicus Therapeutics's revenue is $634M (FY2025, publicly reported).
Selling to companies like Amicus Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies